Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies III: Computed Tomography01:27

Imaging Studies III: Computed Tomography

891
DefinitionComputed Tomography (CT) of the genitourinary (GU) tract is a non-invasive imaging modality that utilizes X-rays and computer processing to generate detailed cross-sectional images of the urinary system, encompassing the kidneys, ureters, bladder, and adjacent structures such as the adrenal glands.PurposeCT scans of the GU tract serve several diagnostic and therapeutic purposes, including:Diagnosis of Urinary Tract Diseases: Detects kidney stones, tumors, cysts, and congenital...
891
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

853
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
853
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

720
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
720
Positron Emission Tomography01:29

Positron Emission Tomography

6.2K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.2K
Imaging Studies IV: Magnetic Resonance Imaging01:27

Imaging Studies IV: Magnetic Resonance Imaging

425
Introduction:Magnetic Resonance Imaging, or MRI, can include a specialized imaging technique of the urinary system known as Magnetic Resonance Urography (MRU). This radiation-free technique uses strong magnetic fields and radio waves to produce detailed images with the help of a computer. MRU is particularly effective for visualizing fluid-filled structures like the kidneys, ureters, and bladder.Applications of MRI in the Genitourinary SystemKidneys and Ureters: MRI detects tumors, cysts,...
425
Computed Tomography01:10

Computed Tomography

7.6K
Tomography refers to imaging by sections. Computed tomography (CT) is a non-invasive imaging technique that uses computers to analyze several cross-sectional X-rays to reveal minute details about structures in the body.
The technique was invented in the 1970s and is based on the principle that as X-rays pass through the body, they are absorbed or reflected at different levels. In the technique, a patient lies on a motorized platform while a computerized axial tomography (CAT) scanner rotates...
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeted Radionuclide Therapy: Current Landscape and Combination Approaches to Improve Oncology Outcomes.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Radioluminescence microscopy of tumor organoids enabled by a reconfigurable high-resolution imaging setup.

EJNMMI research·2026
Same authorSame journal

Toward a Biopsy-Free Diagnosis of Prostate Cancer: Potential of Combined <sup>18</sup>F-Flotufolastat PSMA PET and mpMRI.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

Imaging the hallmarks of cancer.

Nature reviews. Cancer·2026
Same author

Impact of different PSMA PET-based eligibility criteria on outcome of [<sup>177</sup>Lu]Lu-PSMA radioligand therapy using [<sup>18</sup>F]rhPSMA-7/[<sup>18</sup>F]rhPSMA-7.3 (Flotufolastat).

EJNMMI research·2026
Same author

The role of 18F-FDG PET/CT in spinal infections: A comprehensive diagnostic tool.

Brain & spine·2026

Related Experiment Video

Updated: Apr 30, 2026

High-Resolution Cardiac Positron Emission Tomography/Computed Tomography for Small Animals
11:09

High-Resolution Cardiac Positron Emission Tomography/Computed Tomography for Small Animals

Published on: December 16, 2022

3.7K

PET/MR Imaging: A Critical Appraisal.

Wolfgang A Weber1

  • 1Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York ww_petmr@outlook.com.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|May 14, 2014
PubMed
Summary

Positron Emission Tomography/Magnetic Resonance (PET/MR) imaging offers advantages over PET/CT but faces challenges in cancer staging. Future applications may focus on novel radiopharmaceuticals for specific tumor types.

Keywords:
CTMRIPETPET/CTPET/MRIphysics and instrumentation

More Related Videos

Hand-held Clinical Photoacoustic Imaging System for Real-time Non-invasive Small Animal Imaging
09:43

Hand-held Clinical Photoacoustic Imaging System for Real-time Non-invasive Small Animal Imaging

Published on: October 16, 2017

10.4K
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

9.1K

Related Experiment Videos

Last Updated: Apr 30, 2026

High-Resolution Cardiac Positron Emission Tomography/Computed Tomography for Small Animals
11:09

High-Resolution Cardiac Positron Emission Tomography/Computed Tomography for Small Animals

Published on: December 16, 2022

3.7K
Hand-held Clinical Photoacoustic Imaging System for Real-time Non-invasive Small Animal Imaging
09:43

Hand-held Clinical Photoacoustic Imaging System for Real-time Non-invasive Small Animal Imaging

Published on: October 16, 2017

10.4K
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

9.1K

Area of Science:

  • Medical Imaging
  • Oncology
  • Radiochemistry

Background:

  • PET/MR imaging shows promise for cancer detection and characterization but its clinical adoption lags behind PET/CT.
  • Technological hurdles like attenuation correction and logistical complexities hinder widespread PET/MR implementation.
  • Current research primarily evaluates PET/MR for cancer staging, often comparing it to the established PET/CT standard.

Purpose of the Study:

  • To assess the current status and future potential of PET/MR imaging in oncology.
  • To identify challenges and opportunities for advancing PET/MR clinical applications.
  • To explore alternative applications beyond whole-body cancer staging.

Main Methods:

  • Review of existing literature on PET/MR imaging in cancer.
  • Analysis of technological and logistical challenges in PET/MR implementation.
  • Evaluation of current and potential radiopharmaceuticals for PET/MR.

Main Results:

  • PET/MR feasibility is demonstrated, but substantial improvements in cancer staging over PET/CT are not yet evident.
  • High costs and longer acquisition times pose challenges for widespread PET/MR adoption in staging.
  • 18F-FDG PET has limitations for common MR-imaged tumors, necessitating new radiotracers.

Conclusions:

  • PET/MR imaging offers potential benefits like reduced radiation and enhanced soft-tissue contrast.
  • Clinical realization of PET/MR potential may depend on developing novel radiopharmaceuticals and applications beyond current staging protocols.
  • Organ-specific MR imaging could be enhanced by PET/MR, particularly with new tracers for challenging tumor types.